Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

ROTY Edition 1 Volume 81: We Have A Launch Date!

9h seekingalpha
February continues to be our worst month yet, but I focus on positioning the model account for success based on our current plan. (197-0)

SNY / Sanofi SCHEDULE TO AMENDMENT NO. 3

2018-02-20 sec.gov
Schedule TO Amendment No. 3     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 3)     Bioverativ Inc. (Name of Subject Company (Issuer))     BLINK ACQUISITION CORP. SANOFI-AVENTIS NA HOLDING, INC. SANOFI-AVENTIS AMERIQUE DU NORD SANOFI (Names of Filing Persons — Offerors)     Common Stock, Par Value $0.

SNY / Sanofi SCHEDULE TO AMENDMENT NO. 3

2018-02-20 sec.gov
Schedule TO Amendment No. 3     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 (Amendment No. 3)     Bioverativ Inc. (Name of Subject Company (Issuer))     BLINK ACQUISITION CORP. SANOFI-AVENTIS NA HOLDING, INC. SANOFI-AVENTIS AMERIQUE DU NORD SANOFI (Names of Filing Persons — Offerors)     Common Stock, Par Value $0.

SNY / Sanofi SC TO-C

2018-02-20 sec.gov
SC TO-C     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934     Ablynx NV (Name of Subject Company (Issuer)) Sanofi (Name of Filing Persons (Offeror)) Ordinary Shares, no par value American Depositary Shares, each of which represents one Ordinary Share (Title of Class of Securities) BE0003877942 (Ordinary Shares) 00372Y105 (American Depositary Shares) (CU

SNY / Sanofi SC TO-C

2018-02-20 sec.gov
SC TO-C     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE TO Tender Offer Statement Pursuant to Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934     Ablynx NV (Name of Subject Company (Issuer)) Sanofi (Name of Filing Persons (Offeror)) Ordinary Shares, no par value American Depositary Shares, each of which represents one Ordinary Share (Title of Class of Securities) BE0003877942 (Ordinary Shares) 00372Y105 (American Depositary Shares) (CU

Biotechs: Still Well Placed For More Gains

2018-02-20 seekingalpha
Big Pharma has to build out pipelines in new areas, and M&A is a compelling alternative. (719-3)

Your Daily Pharma Scoop: AbbVie's Upadacitinib, Johnson & Johnson's Tremfya, Celgene Reports Results For Otezla

2018-02-19 seekingalpha
Today we will discuss AbbVie (ABBV), which continues to have a phenomenal run in 2018 even as sentiment on the broader equity market has turned negative. (144-0)

Merger And Acquisition: What Can Investors Learn From The Seattle Genetics Buyout Of Cascadian?

2018-02-18 seekingalpha
This M&A satisfied 50% of our criteria conducive to a buyout. For one, there is pipeline synergy. (107-1)

Amicus Therapeutics: Regulatory Update And Financing Add To Bull Case

2018-02-17 seekingalpha
Shares have come a long way since my original recommendation and are currently trading about 10% under the 52-week high. (23-1)

BioXcel Therapeutics Seeks $69 Million U.S. IPO

2018-02-16 seekingalpha
The firm is using the advanced data and AI technologies of its parent company to improve its drug development efforts. (381-3)

ROTY Edition 1 Volume 80: Adding To Select Positions And Continuing To Manage Risk

2018-02-16 seekingalpha
I remind readers of our biggest loser to date and why risk management has been key to ROTY`s success. (146-0)

The Zacks Analyst Blog Highlights: ExxonMobil, Caterpillar, Union Pacific, Alexion and Sanofi

2018-02-15 zacks
Chicago, IL – Feb 15, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include ExxonMobil (XOM - Free Report) , Caterpillar (CAT - Free Report) , Union Pacific (UNP - Free Report) , Alexion (ALXN - Free Report) and Sanofi (SNY - Free Report) . (111-0)

Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q4 2017 Update

2018-02-15 seekingalpha
This article is part of a series that provides an ongoing analysis of the changes made to Berkshire Hathaway’s US stock portfolio on a quarterly basis. It is based on Warren Buffett’s regulatory 13F Form filed on 02/14/2018. Please visit our Tracking 10 Years Of Berkshire Hathaway's Investment Portfolio article series for an idea on how his holdings have progressed over the years and our previous update for the moves in Q3 2017. (713-13)

Top Research Reports for ExxonMobil, Caterpillar & Union Pacific

2018-02-15 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), Caterpillar (CAT) and Union Pacific (UNP). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. (121-0)

Berkshire buys Teva, feels IBM blues as Apple becomes top investment

2018-02-15 reuters
(Reuters) - Warren Buffett’s Berkshire Hathaway Inc (BRKa.N) on Wednesday disclosed a new stake in generic drugmaker Teva Pharmaceutical Industries Ltd (TEVA.TA) and said it bought more shares of Apple Inc (AAPL.O), which surpassed Wells Fargo & Co (WFC.N) as its largest common stock investment. (359-2)


CUSIP: 80105N105